Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

COMPARATIVE EFFECTS OF DRY NEEDLING AND NEURAL MOBILIZATION ON PAIN, STRENGTH AND RANGE OF MOTION IN PATIENTS WITH GOLFER'S ELBOW (DN-NM-GE)

8. juni 2026 opdateret af: Abeela Ashraf, Green International University
This randomized clinical trial aims to compare the effectiveness of Dry Needling and Neural Mobilization in patients diagnosed with Golfer's Elbow (Medial Epicondylitis). The study will evaluate the effects of both interventions on pain intensity, grip strength, and range of motion. Participants will be randomly allocated to either the Dry Needling group or the Neural Mobilization group and treated over a specified intervention period. Outcome measures will be assessed at baseline and after treatment to determine which intervention provides greater improvement in pain reduction, muscle strength, and functional mobility. The results may contribute to evidence-based rehabilitation strategies for managing Golfer's Elbow

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Golfer's Elbow (Medial Epicondylitis) is a common musculoskeletal disorder characterized by pain and tenderness over the medial epicondyle of the elbow, often associated with repetitive wrist flexion and forearm pronation activities. The condition can lead to decreased grip strength, restricted range of motion, and impaired functional performance, affecting daily activities and quality of life.

Various physiotherapy interventions have been used for the management of Golfer's Elbow, including Dry Needling and Neural Mobilization. Dry Needling is a technique that targets myofascial trigger points to reduce pain, improve blood flow, and restore muscle function. Neural Mobilization aims to restore the normal mobility and physiological function of peripheral nerves by reducing neural tension and improving neural mechanics.

The purpose of this randomized clinical trial is to compare the effectiveness of Dry Needling and Neural Mobilization in reducing pain, improving grip strength, and increasing range of motion in patients with Golfer's Elbow. Eligible participants will be randomly assigned to one of two intervention groups. Baseline assessments will be conducted before treatment, followed by post-intervention assessments after completion of the treatment protocol.

Primary outcome measures will include pain intensity, assessed using a validated pain scale, while secondary outcomes will include grip strength and elbow/wrist range of motion. Data collected will be analyzed to determine whether one intervention demonstrates superior clinical outcomes compared to the other.

The findings of this study are expected to provide evidence regarding the comparative effectiveness of these commonly used physiotherapy interventions and may assist clinicians in selecting appropriate treatment strategies for patients with Golfer's Elbow.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

29

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Pakistan
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Green International University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • • Both male and female patients were included.

    • Diagnosis of Medial Epicondylitis by spiral test clinically confirmed by orthopaedic.

pain is limited on medial epicondyle

  • Pain reproduced with resisted wrist flexion and/or forearm pronation.
  • Aged between 18-40 years
  • Acute to Subacute stage (≥ 6 weeks and ≤ 12 months
  • NPRS score ≥ 4/10 at baseline

Exclusion Criteria:

  • • History of Other elbow pathologies e.g (Lateral epicondylitis , Olecranon bursitis ,Ligament injuries)

    • Radial or ulnar neuropathies not associated with medial epicondylitis.
    • Systemic or inflammatory conditions affecting tendons, such as rheumatoid arthritis
    • Diabetes with neuropathy (unless controlled and neuropathy absent)
    • Previous surgical procedures around the elbow or wrist within the past 6 months
    • Corticosteroid injection, PRP or shockwave therapy within the last 3 months

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Dry needling
Participants will receive dry needling combined with conventional physiotherapy twice weekly for 6 weeks
Procedure: Dry needling
Participants will receive dry needling to the affected forearm muscles along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion
Procedure: Neural mobilization
Participants will receive neural mobilization techniques along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion.
Eksperimentel: Neural mobilization
Participants will receive neural mobilization combined with conventional physiotherapy twice weekly for 6 weeks
Procedure: Dry needling
Participants will receive dry needling to the affected forearm muscles along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion
Procedure: Neural mobilization
Participants will receive neural mobilization techniques along with conventional physiotherapy. Treatment will be administered twice weekly for 6 weeks, totaling 12 sessions. Outcomes will include pain, grip strength, and range of motion.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Pain intensity
Tidsramme: Baseline and at 6 weeks post-intervention
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores represent greater pain intensity.
Baseline and at 6 weeks post-intervention

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Grip strength
Tidsramme: Baseline and at 6 weeks post-intervention
Grip strength will be measured using a hand dynamometer. Higher values indicate greater muscle strength.
Baseline and at 6 weeks post-intervention
Range of motion
Tidsramme: Baseline and at 6 weeks post-intervention
Elbow and wrist range of motion will be measured using a standard goniometer. Higher values indicate improved joint mobility.
Baseline and at 6 weeks post-intervention

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Green International University

Efterforskere

  • Ledende efterforsker: Prof Dr Fahad Tanveer, Green international University lahore

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. januar 2025

Primær færdiggørelse (Faktiske)

5. marts 2026

Studieafslutning (Faktiske)

10. maj 2026

Datoer for studieregistrering

Først indsendt

8. juni 2026

Først indsendt, der opfyldte QC-kriterier

8. juni 2026

Først opslået (Faktiske)

11. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

11. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

8. juni 2026

Sidst verificeret

1. juni 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • GIU/REC/26-41

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Due to patients privacy and confidentiality , IPD will not be shared

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Medial epikondylitis

Kliniske forsøg med Dry needling

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Germany

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner